The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Bile acids initiate cholestatic liver injury by triggering a hepatocyte-specific inflammatory response
Open accessAbstract
Mechanisms of bile acid–induced (BA-induced) liver injury in cholestasis are controversial, limiting development of new therapies. We examined how BAs initiate liver injury using isolated liver cells from humans and mice and in-vivo mouse models. At pathophysiologic concentrations, BAs induced proinflammatory cytokine expression in mouse and human hepatocytes, but not in nonparenchymal cells or cholangiocytes. These hepatocyte-specific cytokines stimulated neutrophil chemotaxis. Inflammatory injury was mitigated in Ccl2 –/– mice treated with BA or after bile duct ligation, where less hepatic infiltration of neutrophils was detected. Neutrophils in periportal areas of livers from cholestatic patients also correlated with elevations in their serum aminotransferases. This liver-specific inflammatory response required BA entry into hepatocytes via basolateral transporter Ntcp. Pathophysiologic levels of BAs induced markers of ER stress and mitochondrial damage in mouse hepatocytes. Chemokine induction by BAs was reduced in hepatocytes from Tlr9 –/– mice, while liver injury was diminished both in conventional and hepatocyte-specific Tlr9 –/– mice, confirming a role for Tlr9 in BA-induced liver injury. These findings reveal potentially novel mechanisms whereby BAs elicit a hepatocyte-specific cytokine-induced inflammatory liver injury that involves innate immunity and point to likely novel pathways for treating cholestatic liver disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Circulating mitochondrial DAMPs cause inflammatory responses to injury
Zhang, Q., Raoof, M., Chen, Y., Sumi, Y., Sursal, T., Junger, W., Brohi, K., Itagaki, K., & Hauser, C. J. (2010) · Nature · doi:10.1038/nature08780 · Cited by 3,812 · cited 1×
“Mitochondrial DNA (mtDNA) has been identified as a damage-associated molecular pattern that can activate Tlr9 (18).”
BackgroundSelf-citationRoles for chemokines in liver disease
Marra, F., & Tacke, F. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.06.043 · Cited by 829 · cited 1×
“As demonstrated in this report, the hepatocyte that is injured by BA first sends out signaling molecules, e.g., che-moattractants, to recruit immune cells to initiate a resolve-or-heal response similar to other forms of liver injury (31).”
BackgroundToxic bile salts induce rodent hepatocyte apoptosis via direct activation of Fas
Faubion, W. A., Guicciardi, M. E., Miyoshi, H., Bronk, S. F., Roberts, P. J., Svingen, P. A., Kaufmann, S. H., & Gores, G. J. (1999) · Journal of Clinical Investigation · doi:10.1172/jci4765 · Cited by 536
Bile Acids Induce Inflammatory Genes in Hepatocytes
Allen, K., Jaeschke, H., & Copple, B. L. (2011) · The American Journal of Pathology · doi:10.1016/j.ajpath.2010.11.026 · Cited by 501
Hepatocyte mitochondrial DNA drives nonalcoholic steatohepatitis by activation of TLR9
Garcia-Martinez, I., Santoro, N., Chen, Y., Hoque, R., Ouyang, X., Caprio, S., Shlomchik, M. J., Coffman, R. L., Candia, A., & Mehal, W. Z. (2016) · Journal of Clinical Investigation · doi:10.1172/jci83885 · Cited by 498 · cited 1×
“The details of Tlr9 fl/fl creation were published elsewhere (33).”
BackgroundSelf-citationHepatocyte Death: A Clear and Present Danger
Malhi, H., Guicciardi, M. E., & Gores, G. J. (2010) · Physiological Reviews · doi:10.1152/physrev.00061.2009 · Cited by 477
CCR2 promotes hepatic fibrosis in mice #
Seki, E., de Minicis, S., Inokuchi, S., Taura, K., Miyai, K., van Rooijen, N., Schwabe, R. F., & Brenner, D. A. (2009) · Hepatology · doi:10.1002/hep.22952 · Cited by 416
Innate immune recognition of infected apoptotic cells directs TH17 cell differentiation
Torchinsky, M. B., Garaude, J., Martin, A. P., & Blander, J. M. (2009) · Nature · doi:10.1038/nature07781 · Cited by 364
Neutrophils Aggravate Acute Liver Injury During Obstructive Cholestasis in Bile Duct-Ligated Mice
Gujral, J. S., Farhood, A., Bajt, M. L., & Jaeschke, H. (2003) · Hepatology · doi:10.1053/jhep.2003.50341 · Cited by 342
Fickert, P., Wagner, M., Marschall, H., Fuchsbichler, A., Zollner, G., Tsybrovskyy, O., Zatloukal, K., Liu, J., Waalkes, M. P., Cover, C., et al. (2006) · Gastroenterology · doi:10.1053/j.gastro.2005.10.018 · Cited by 300
Bile acids as metabolic regulators
Li, T., & Chiang, J. Y. L. (2015) · Current Opinion in Gastroenterology · doi:10.1097/mog.0000000000000156 · Cited by 269
Spivey, J. R., Bronk, S. F., & Gores, G. J. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116546 · Cited by 256
Cytoplasmic DNA innate immune pathways
Barber, G. N. (2011) · Immunological Reviews · doi:10.1111/j.1600-065x.2011.01051.x · Cited by 245
Botla, R., Spivey, J. R., Aguilar, H., Bronk, S. F., & Gores, G. J. (1995) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)24517-7 · Cited by 228
Vaz, F. M., Paulusma, C. C., Huidekoper, H., de Ru, M., Lim, C., Koster, J., Ho‐Mok, K., Bootsma, A. H., Groen, A. K., Schaap, F. G., et al. (2015) · Hepatology · doi:10.1002/hep.27240 · Cited by 217
Effect of bile duct ligation on bile acid composition in mouse serum and liver
Zhang, Y., Hong, J., Rockwell, C. E., Copple, B. L., Jaeschke, H., & Klaassen, C. D. (2012) · Liver International · doi:10.1111/j.1478-3231.2011.02662.x · Cited by 204
Bile acid-induced necrosis in primary human hepatocytes and in patients with obstructive cholestasis
Woolbright, B. L., Dorko, K., Antoine, D. J., Clarke, J. I., Gholami, P., Li, F., Kumer, S. C., Schmitt, T. M., Forster, J., Fan, F., et al. (2015) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2015.01.015 · Cited by 190
The Bile Acid Glycochenodeoxycholate Induces TRAIL-Receptor 2/DR5 Expression and Apoptosis
Higuchi, H., Bronk, S. F., Takikawa, Y., Werneburg, N., Takimoto, R., El-Deiry, W., & Gores, G. J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m105300200 · Cited by 186
Slijepcevic, D., Kaufman, C., Wichers, C. G. K., Gilglioni, E. H., Lempp, F. A., Duijst, S., de Waart, D. R., Elferink, R. P. J. O., Mier, W., Stieger, B., et al. (2015) · Hepatology · doi:10.1002/hep.27694 · Cited by 155
Bohan, A., Chen, W., Denson, L. A., Held, M. A., & Boyer, J. L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m304011200 · Cited by 151
Self-citationRole of TLR9 in hepatic stellate cells and experimental liver fibrosis
Gäbele, E., Mühlbauer, M., Dorn, C., Weiß, T. S., Froh, M., Schnabl, B., Wiest, R., Schölmerich, J., Obermeier, F., & Hellerbrand, C. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.08.096 · Cited by 150
Ouyang, X., Ghani, A., Malik, A. F., Wilder, T., Colegio, O. R., Flavell, R. A., Cronstein, B. N., & Mehal, W. Z. (2013) · Nature Communications · doi:10.1038/ncomms3909 · Cited by 144
Self-citationSchoemaker, M. H., Gommans, W. M., de la Rosa, L. C., Buist‐Homan, M., Klok, P. A., Trautwein, C., van Goor, H., Poelstra, K., Haisma, H. J., Jansen, P. L. M., et al. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(03)00214-9 · Cited by 136
Bile duct ligation in rats induces biliary expression of cytokine-induced neutrophil chemoattractant
Saito, J. M., & Maher, J. J. (2000) · Gastroenterology · doi:10.1016/s0016-5085(00)70369-6 · Cited by 130
Kupffer Cells Abrogate Cholestatic Liver Injury in Mice
Gehring, S., Dickson, E. M., Martin, M. E. S., van Rooijen, N., Papa, E. F., Harty, M. W., Tracy, T. F., & Gregory, S. H. (2006) · Gastroenterology · doi:10.1053/j.gastro.2005.11.015 · Cited by 129
Cai, S., Gautam, S., Nguyen, T., Soroka, C. J., Rahner, C., & Boyer, J. L. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.10.025 · Cited by 119
Self-citationEarly Growth Response Factor-1 Is Critical for Cholestatic Liver Injury
Kim, N. D., Moon, J.-O., Slitt, A. L., & Copple, B. L. (2006) · Toxicological Sciences · doi:10.1093/toxsci/kfj111 · Cited by 114
Spirlì, C., Okolicsanyi, S., Fiorotto, R., Fabris, L., Cadamuro, M., Lecchi, S., Tian, X., Somlo, S., & Strazzabosco, M. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.09.005 · Cited by 99
Woolbright, B. L., Antoine, D. J., Jenkins, R. E., Bajt, M. L., Park, B. K., & Jaeschke, H. (2013) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2013.09.023 · Cited by 98
IL-17A Synergistically Enhances Bile Acid–Induced Inflammation during Obstructive Cholestasis
O'Brien, K. M., Allen, K. M., Rockwell, C. E., Towery, K., Luyendyk, J. P., & Copple, B. L. (2013) · American Journal Of Pathology · doi:10.1016/j.ajpath.2013.07.019 · Cited by 85
Carchman, E. H., Whelan, S., Loughran, P., Mollen, K. P., Stratamirovic, S., Shiva, S., Rosengart, M. R., & Zuckerbraun, B. S. (2013) · The FASEB Journal · doi:10.1096/fj.13-229476 · Cited by 79
Sasaki, M., Miyakoshi, M., Sato, Y., & Nakanuma, Y. (2013) · Digestive Diseases and Sciences · doi:10.1007/s10620-013-2920-6 · Cited by 76
Sombetzki, M., Fuchs, C. D., Fickert, P., Österreicher, C. H., Mueller, M., Claudel, T., Loebermann, M., Engelmann, R., Langner, C., Sahin, E., et al. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.11.020 · Cited by 68
Therapeutic targets for cholestatic liver injury
Woolbright, B. L., & Jaeschke, H. (2015) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2016.1103735 · Cited by 54
Denk, G., Kleiss, C. P., Wimmer, R., Vennegeerts, T., Reiter, F. P., Schulz, S., Zischka, H., & Rust, C. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.07.029 · Cited by 33
Serum IL-6 and IL-8 in infants with biliary atresia in comparison to intrahepatic cholestasis
Elfaramawy, A. A., El-Shazly, L. B., Abbass, A. A., & Ismail, H. A. (2011) · Tropical Gastroenterology · doi:10.4103/trog_20103201_50 · Cited by 32
Current pharmacotherapy for cholestatic liver disease
Carey, E. J., & Lindor, K. D. (2012) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2012.736491 · Cited by 32
Cai, S., Mennone, A., Soroka, C. J., & Boyer, J. L. (2014) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00334.2013 · Cited by 19
Self-citation
Cited by
Bile Acids Activated Receptors Regulate Innate Immunity
Fiorucci, S., Biagioli, M., Zampella, A., & Distrutti, E. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01853 · Cited by 562
Dysregulated Microbial Fermentation of Soluble Fiber Induces Cholestatic Liver Cancer
Singh, V., Yeoh, B. S., Chassaing, B., Xiao, X., Saha, P., Aguilera Olvera, R., Lapek, J. D., Zhang, L., Wang, W.-B., Hao, S., et al. (2018) · Cell · doi:10.1016/j.cell.2018.09.004 · Cited by 532
Emerging roles of bile acids in mucosal immunity and inflammation
Chen, M. L., Takeda, K., & Sundrud, M. S. (2019) · Mucosal Immunology · doi:10.1038/s41385-019-0162-4 · Cited by 298
Mechanisms of bile acid mediated inflammation in the liver
Li, M., Cai, S.-Y., & Boyer, J. L. (2017) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2017.06.001 · Cited by 271
Self-citationGhallab, A., Hofmann, U., Sezgin, S., Vartak, N., Hassan, R., Zaza, A., Godoy, P., Schneider, K. M., Guenther, G., Ahmed, Y. A., et al. (2019) · Hepatology · doi:10.1002/hep.30213 · Cited by 101
“It has been reported that mitigating the inflammatory response can reduce the extent of necrosis after BDL.(23) This”
Background
Metadata
- Authors
- Cai, S.-Y., Ouyang, X., Chen, Y., Soroka, C. J., Wang, J., Mennone, A., Wang, Y., Mehal, W. Z., Jain, D., & Boyer, J. L.
- Venue
- JCI Insight
- Published
- 2017-03-09
- Volume
- 2
- Issue
- 5
- Pages
- e90780-e90780
- ISSN
- 2379-3708 (ISSN-L)
- OpenAlex
- W2593604375
- Cited by
- 255
- References
- 38
- FWCI
- 25.68
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.